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Background: Physiology-based severity of illness scores are often used for risk adjustment 
in observational studies of intensive care unit (ICU) outcome. However, the complexity and 
time constraints of these scoring systems may limit their use in administrative databases. 
Comorbidity is a main determinant of ICU outcome, and comorbidity scores can be computed 
based on data from most administrative databases. However, limited data exist on the perfor-
mance of comorbidity scores in predicting mortality of ICU patients.
Objectives: To examine the performance of the Charlson comorbidity index (CCI) alone and 
in combination with other readily available administrative data and three physiology-based 
scores (acute physiology and chronic health evaluations [APACHE] II, simplified acute physiol-
ogy score [SAPS] II, and SAPS III) in predicting short- and long-term mortality following 
intensive care.
Methods: For all adult patients (n = 469) admitted to a tertiary university–affiliated ICU in 
2007, we computed APACHE II, SAPS II, and SAPS III scores based on data from medical 
records. Data on CCI score age and gender, surgical/medical status, social factors, mechani-
cal ventilation and renal replacement therapy, primary diagnosis, and complete follow-up 
for 1-year mortality was obtained from administrative databases. We computed goodness-
of-fit statistics and c-statistics (area under ROC [receiver operating characteristic] curve) as 
measures of model calibration (ability to predict mortality proportions over classes of risk) 
and discrimination (ability to discriminate among the patients who will die or survive), 
respectively.
Results: Goodness-of-fit statistics supported model fit for in-hospital, 30-day, and 1-year 
mortality of all combinations of the CCI score. Combining the CCI score with other administra-
tive data revealed c-statistics of 0.75 (95% confidence interval [CI] 0.69–0.81) for in-hospital 
mortality, 0.75 (95% CI 0.70–0.80) for 30-day mortality, and 0.72 (95% CI 0.68–0.77) for 
1-year mortality. There were no major differences in c-statistics between physiology-based 
systems and the CCI combined with other administrative data.
Conclusion: The CCI combined with administrative data predict short- and long-term mortality 
for ICU patients as well as physiology-based scores.
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Introduction
Within intensive care medicine, limited evidence is available from randomized con-
trolled trials (RCTs).1 The heterogeneity and complex clinical course of intensive care 
unit (ICU) patients makes it difficult to standardize treatment as required in RCTs and 
to maintain randomized assignments. Therefore, large health care databases   
are increasingly used to study outcomes of ICU interventions.1–6Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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The validity of observational studies on ICU outcomes 
depends, among other factors, on appropriate risk adjustment 
for case-mix differences. A number of physiology-based 
severity of illness scoring systems have been developed to 
adjust for case mix in observational studies of ICU outcomes, 
such as the simplified acute physiology scores (SAPS),7 the 
acute physiology and chronic health evaluations (APACHE),8 
and the mortality probability models (MPM).9 These systems 
were developed to estimate the probability of in-hospital 
mortality based on a summary score consisting of measures 
of physiological derangement in combination with demo-
graphics, comorbidity, and reason for ICU admission. 
In contrast to older models (SAPS II and APACHE II), newer 
models (SAPS III) achieve a substantially larger part of the 
predictive power, with data available before ICU admission, 
including comorbidity and reason for ICU admission. 
However, the complexity and time constraints of the 
physiology-based scoring systems limit their use in large 
population-based databases.
Comorbidity has been shown to be an important 
determinant of ICU outcome.10–12 This is underlined by the 
increasing weight ascribed to comorbidity in the most recent 
developed severity-of-illness models, such as the SAPS III 
model. The Charlson comorbidity index (CCI),13,14 developed 
to predict 1-year mortality among medical patients, is one 
of the most frequently used measures of comorbidity.15 
However, only four studies examined the performance of 
comorbidity scores in predicting in-hospital mortality in ICU 
patients.11,16–18 The studies either did not combine the comor-
bidity score with other readily available administrative 
data11,18 or included special study populations, such as 
patients from Veterans Affairs hospitals.11 A recent 
Australian study examined the performance of the CCI in 
combination with APACHE II data to predict long-term 
mortality of ICU patients.12 No data for the CCI exclusively 
was presented.
We therefore examined the performance of the CCI alone 
and in combination with other readily available administra-
tive data and three physiology-based scoring systems 
(APACHE II, SAPS II, and SAPS III) in predicting short-term 
mortality (in-hospital and 30-day) and long-term mortality 
(1-year) in a cohort of Danish ICU patients.
Methods
The study population included all patients older than 15 years 
admitted to the ICU at Aarhus University Hospital, Skejby, 
Denmark, between January 1, 2007 and December 31, 2007. 
We included only each patient’s first ICU admission during 
the study period. We did not include in the cohort coronary 
care patients, or cardiac surgery patients and other patients 
admitted for planned postoperative observation of less than 
24 hours as defined in the original physiology-based 
models.7,9,19 The 14-bed facility is a highly specialized 
university-affiliated surgical/medical tertiary unit serving as 
both a primary and referral ICU. The nurse to patient ratio 
is 1:1. Patients are admitted from departments of thoracic 
surgery or cardiology, as well as from departments of infec-
tious diseases, gynecology and obstetrics, nephrology, and 
urology. Its patients include those with severe respiratory 
insufficiency requiring extracorporeal membrane oxygen-
ation and patients undergoing organ transplantation.
The Danish national health care system provides the 
entire Danish population with unrestricted access to tax-
supported public health services. In Denmark, all critically 
ill patients receive care in public hospitals.
Since 1968, every Danish citizen has received at birth a 
unique civil registration number that encodes age, gender, 
and date of birth. This number is included in all Danish 
registries and permits accurate linkage among registries.
Comorbidity
We obtained data on comorbidity from the Danish National 
Registry of Patients (DNRP). For all hospital admissions to 
Danish acute care hospitals since 1977 and, since 1995, for 
all hospital outpatient and emergency room visits (more than 
99% complete), the DNRP has recorded the patients’ civil 
registration numbers, dates of admission and discharge, up 
to 20 surgical procedures, and up to 20 discharge diagnoses, 
classified according to the International Classification of 
Diseases, eighth revision (ICD-8), until the end of 1993 and 
tenth revision (ICD-10) thereafter.20 All hospital diagnoses 
were coded by the physician treating the patient at the time 
of hospital discharge. Since 2005, treatments such as 
mechanical ventilation and renal replacement therapy have 
also been registered.
We used the CCI to estimate comorbidity levels among 
study patients.13 In calculating the CCI, a weight (1–6) is 
assigned to each of 19 comorbid disease categories, and the 
score is the sum of these weights. We used a version of the 
Deyo ICD-9 adaptation of the CCI,15 modified for use with 
ICD-8 and ICD-10 discharge codes (see Appendix 1). Using 
the DNRP, we identified all study patients’ post-1977 hos-
pital diagnoses registered before the date of ICU admission. 
In a sensitivity analysis, we restricted comorbidity informa-
tion to the 5 years prior to ICU admission. The score was 
included as a continuous covariate in the analysis. Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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The comorbid diseases and predefined weights in the CCI 
may not necessarily be the optimal choice for an ICU 
population. We therefore also conducted analyses, including 
ten separate clinically relevant comorbidity categories based 
on the original 19 comorbid disease categories in the CCI 
(see Appendix).
Other administrative data
We used the DNRP to identify the primary hospital diagnosis 
for all hospital stays that included ICU care and grouped 
patients into eight diagnostic categories: (1) infectious 
diseases; (2) endocrinology, including diabetes; (3) cardio-
vascular diseases; (4) respiratory diseases; (5) gastrointesti-
nal and liver diseases; (6) cancer; (7) trauma and poisoning; 
and (8) others (details on ICD codes are provided in the 
Appendix). Using the DNRP, we also obtained information 
on surgical procedures performed on all study patients. We 
defined surgical patients as patients who underwent surgery 
on the day of ICU admission or within 7 days before that 
date and medical patients as those who had no surgery within 
7 days before ICU admission.7 Data on mechanical ventila-
tion and renal replacement therapy in the ICU were obtained 
from the DNRP. Through the Civil Registration System, we 
obtained data on marital status (married, divorced, widowed, 
never married, or unknown) and urbanization (city, town, or 
provincial town) as measures of social status.21
Physiology-based scores
To obtain data on physiology-based scores (SAPS II, 
SAPS III, APACHE II), two reviewers (SC, CFC) reviewed 
all medical records for study patients (for details on the scores, 
see Appendix Table C). Data on physiological variables were 
obtained from a computerized patient-data management 
system (Picis Critical Care Manager, Picis Inc, Wakefield, 
MA) that prospectively collects a wide range of clinical 
information, including detailed data on mechanical ventila-
tion, body temperature, blood pressure, and heart rate. From a 
computerized laboratory database, we obtained the laboratory 
data included in the physiology-based scores (hemoglobin, 
white blood cell count, creatinine, and urea). All clinical data 
were reviewed; this allowed us to avoid including invalid data 
from the computerized databases, for example, incorrect 
blood pressure measured during sampling blood from an 
arterial line. Data on reason for ICU admission were obtained 
from medical records. We used the original definitions of all 
variables in the APACHE II, SAPS II, and SAPS III systems. 
The Glasgow Coma Scale (GCS) score is difficult to assess 
based on review of medical records.22 We assumed a normal 
GCS score (=15) if the GCS score was not described in the 
medical record or if the patient was sedated upon ICU 
admission. While the study design called for the reviewers 
to be blinded to the study endpoint, in practice it was not 
possible to obtain perfect blinding for in-hospital mortality.
record linkage and mortality
Since 1968, every Danish citizen has received at birth a 
unique personal identifier, a civil registration number encod-
ing gender and date of birth. This number is included in all 
Danish registries and permits accurate linkage among 
registries.21 The Danish Civil Registration System provides 
information on vital status and residence for the entire Danish 
population, updated daily since 1968. Using this database, 
we were able to track the study outcomes – that is, in-hospital 
mortality, 30-day mortality, and 1-year mortality – following 
the date of first ICU admission during the study period.
statistical analysis
We used medians and interquartile ranges (IQRs) to describe 
the distribution of scores within the cohort of ICU patients. 
We computed Spearman’s rank correlation coefficient for 
correlation among scores.
For each endpoint (in-hospital, 30-day, and 1-year 
mortality) logistic regression models were constructed for 
the following eleven combinations of variables: (1) CCI 
score; (2) CCI, age, gender; (3) CCI, age, gender, surgical/
medical status; (4) CCI, age, gender, surgical/medical status, 
social factors; (5) CCI, age, gender, surgical/medical status, 
social factors, mechanical ventilation and renal replacement 
therapy; (6) CCI, age, gender, surgical/medical status, social 
factors, mechanical ventilation and renal replacement 
therapy, primary diagnosis; (7) ten separate comorbidity 
groups; (8) ten comorbidity groups in combination with age, 
gender, surgical/medical status, social factors, mechanical 
ventilation and renal replacement therapy, primary diagnosis; 
(9) SAPS II; (10) SAPS III; and (11) APACHE II.
We used Hosmer–Lemeshow goodness-of-fit statistics 
to assess model calibration except for the model including 
CCI only and the model including the ten separate comorbid-
ity groups only. In these two models we used Pearson’s 
chi-square statistics because of the limited number of 
observed and expected deaths in the higher deciles of risk.
For all models, c-statistics (area under ROC [receiver 
operating characteristic] curve) were calculated as a mea-
sure of a model’s ability to discriminate between survivors 
and nonsurvivors. c-statistics range from 0 to 1, with 1 indi-
cating perfect discrimination and 0.5 indicating a chance Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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discrimination; a c-statistic between 0.7 and 0.8 is 
considered a good discrimination, and a c-statistic .0.8 an 
excellent discrimination.23
To assess the impact of length of follow-up for comorbid-
ity included in the CCI, we reran the analysis including 
comorbidity information from the 5 years prior to ICU admis-
sion only.
To assess whether colinearity may have influenced our 
analysis, we reran our models using multiple linear regression 
with a binary dependent variable. While this model is clearly 
not a correct one and violates key assumptions, it allows us 
to run diagnostic tests for colinearity among the independent 
variables. These measures (VIF [variance inflation factor] 
and its reciprocal, tolerance) were examined and showed no 
indication that colinearity is a factor in our multivariable 
analyses (data not shown).
Results
We identified 469 adult ICU patients during the study period. 
The majority of patients (66.9%) were older than 60 years, 
and 298 (63.5%) patients had surgery within 7 days before 
ICU admission (Table 1). Cardiovascular diagnoses such 
as ischemic heart diseases were the primary diagnoses for 
the majority of patients (58.9%). Median CCI score was 
2 (IQR 1–3), and median score was 16 (IQR 11–21) for 
APACHE II, 36 (IQR 26–47) for SAPS II, and 57 (IQR 
45–66) for SAPS III.
Correlation
The correlation was poor between CCI score and SAPS 
scores and only slightly better for the CCI and APACHE II 
scores (Table 2). The correlation among the physiology-
based scores was moderate to high.
Calibration
The Hosmer–Lemeshow goodness-of-fit statistics supported 
model fit of all models for in-hospital, 30-day, and 1-year 
mortality, as indicated by P-values being above 0.05 
(Table 3).
Discrimination
For the model including only the CCI, the ability to dis-
criminate between survivors and nonsurvivors of the current 
hospitalization was poor (c-statistic = 0.52; 95% confidence 
interval [CI] 0.46–0.59), as well as within 30 days 
(c-statistic = 0.52; 95% CI 0.46–0.57) and 1 year of ICU 
admission (c-statistic = 0.58; 95% CI 0.53–0.63) (Table 4). 
Adding age, gender, social factors, surgical/medical status, 
mechanical ventilation/renal replacement therapy, and 
primary diagnosis to the CCI score in a multivariable model 
improved the discrimination substantially, with c-statistics 
of 0.75 (95% CI 0.69–0.81) for in-hospital mortality, 0.75 
(95% CI 0.70–0.80) for 30-day mortality, and 0.72 (95% 
CI 0.68–0.77) for 1-year mortality. Physiology-based scores 
Table 2 Correlation among scoring systems (spearman’s rank 
coefficient)
SAPS II SAPS III APACHE II
Charlson score 0.124  
(P = 0.0074)
0.082  
(P = 0.0750)
0.228  
(P , 0.0001)
sAPs ii - 0.691  
(P , 0.0001)
0.770  
(P , 0.0001)
sAPs iii - 0.659  
(P , 0.0001)
Abbreviations: APAChE, acute physiology and chronic health evaluations; sAPs, 
simplified acute physiology score.
Table  1  Characteristics  of  469  adult  iCU  patients,  Aarhus 
University hospital, skejby, Denmark, 2007
Characteristic Number %
Gender
Women 158 33.7%
Men 311 66.3%
Age group
15–45 47 10.0%
46–60 108 23.0%
61–75 192 40.9%
76+ 122 26.0%
Surgical/Medical statusa
Medical 171 36.5%
surgical 298 63.5%
Primary diagnosis
infectious disease 18 3.8%
Cancer 40 8.5%
Diabetes 2 0.4%
Cardiovascular disease 276 58.9%
respiratory disease 40 8.5%
gastrointestinal disease 11 2.4%
Trauma/poisoning 5 1.1%
Other 77 16.4%
Treatment
Mechanical ventilation  320 68.2%
renal replacement therapy 126 26.9%
Marital status
Married 275 58.6%
never married 59 12.6%
Divorced 49 10.5%
Widow(er) 84 17.9%
Unknown 2 0.4%
Urbanization
Provincial town 186 39.7%
Town 153 32.6%
City 130 27.7%
Note: asurgery within 7 days before iCU admission. 
Abbreviation: iCU, intensive care unit.Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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Table 3 Model calibration assessed by Hosmer–Lemeshow goodness-of-fit statistics and Pearson’s chi-square
Score/measure In-hospital mortality 30-day mortality 1-year mortality
H-L  
goodness-of-fit*
DF P-value H-L  
goodness-of-fit*
DF P-value H-L  
goodness-of-fit*
DF P-value
Charlson score* 14.65* 9 0.10 8.97* 9 0.44 15.61* 9 0.08
Charlson score, age and gender 8.92 8 0.35 6.91 8 0.55 8.06 8 0.43
Charlson score, age and gender,  
surgical/medical status
7.40 8 0.49 11.66 8 0.17 9.13 8 0.33
Charlson score, age and gender,  
surgical/medical status, social factors
6.26 8 0.62 2.69 8 0.95 4.10 8 0.85
Charlson score, age and gender,  
surgical/medical status, social  
factors, mechanical ventilation  
and renal replacement therapy
13.80 8 0.09 10.23 8 0.25 12.12 8 0.15
Charlson score, age and gender,  
surgical/medical status, social factors, 
mechanical ventilation and renal  
replacement therapy, primary diagnosis
12.26 8 0.14 9.07 8 0.34 10.48 8 0.23
Ten separate comorbidity groups* 85.30* 92 0.68 85.49* 92 0.67 106.12* 92 0.15
Ten comorbidity groups, with age,  
gender, surgical/medical status, social  
factors, mechanical ventilation and renal 
replacement therapy, primary diagnosis
7.79 8 0.45 8.89 8 0.35 7.38 8 0.50
sAPs ii 4.37 10 0.93 3.49 10 0.97 1.58 10 1.00
sAPs iii 9.23 10 0.51 10.89 10 0.37 11.55 10 0.32
APAChE ii 13.66 10 0.19 12.65 10 0.24 8.12 10 0.62
Note: *Pearson chi-square (see text for details).
Abbreviations: APACHE, acute physiology and chronic health evaluations; DF, degrees of freedom; H-L, Hosmer–Lemeshow; SAPS, simplified acute physiology score.
discriminated as well as the CCI in combination with 
administrative data between short-term survivors and 
nonsurvivors. C-statistics for 1-year mortality was 0.70 
(95% CI 0.66–0.75) for SAPS II, 0.69 (95% CI 0.64–0.73) 
for SAPS III, and 0.69 (95% CI 0.64–0.73) for APACHE II.   
Including ten comorbidity groups as separate covariates in 
the regression model only slightly improved discrimination 
compared  with  the  CCI  (c-statistic  for  30-day 
mortality = 0.76; 95% CI 0.71–0.81). Of note, c-statistics 
were almost nearly the same for in-hospital, 30-day, and 
Table 4 c-statistics (area under ROC curve) as measure of discrimination between survivors and nonsurvivors (in-hospital, 30-day, 
and 1-year mortality)
Score/measure Outcome  
c-statistic (95% CI)
In-hospital mortality 30-day mortality 1-year mortality
Mortality 83/469 (17.7%) 117/469 (24.9%) 178/469 (40.0%)
Charlson score 0.52 (0.46–0.59) 0.52 (0.46–0.57) 0.58 (0.53–0.63)
Charlson score, age and gender 0.64 (0.57–0.71) 0.65 (0.59–0.71) 0.65 (0.60–0.70)
Charlson score, age and gender, surgical/medical status 0.67 (0.60–0.7) 0.67 (0.61–0.73) 0.66 (0.61–0.71)
Charlson score, age and gender, surgical/medical status, social factors 0.68 (0.62–0.75) 0.70 (0.64–0.75) 0.68 (0.63–0.73)
Charlson score, age and gender, surgical/medical status, social factors,  
mechanical ventilation and renal replacement therapy
0.72 (0.65–0.78) 0.73 (0.68–0.78) 0.71 (0.67–0.76)
Charlson score, age and gender, surgical/medical status, social factors,  
mechanical ventilation and renal replacement therapy, primary diagnosis
0.75 (0.69–0.81) 0.75 (0.70–0.80) 0.72 (0.68–0.77)
Ten separate comorbidity groups* 0.59 (0.52–0.65) 0.58 (0.52–0.64) 0.63 (0.58–0.68)
Ten comorbidity groups,* with age, gender, surgical/medical status, social factors, 
mechanical ventilation and renal replacement therapy, primary diagnosis
0.75 (0.69–0.82) 0.76 (0.71–0.81) 0.75 (0.70–0.79)
sAPs ii 0.74 (0.69–0.80) 0.72 (0.67–0.75) 0.70 (0.66–0.75)
sAPs iii 0.69 (0.63–0.75) 0.68 (0.63–0.74) 0.69 (0.64–0.73)
APAChE ii 0.73 (0.67–0.78) 0.71 (0.66–0.76) 0.71 (0.66–0.76)
Note: *see text for details.
Abbreviations: APACHE, acute physiology and chronic health evaluations; CI, confidence interval; ROC, receiver operating characteristic; SAPS, simplified acute 
physiology score.Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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1-year mortality within the same categories of comorbidity 
measures.
Including data on comorbidity from within 5 years prior 
to ICU admission had virtually no influence on c-statistics 
for the CCI models (data not shown).
Discussion
In this study of 469 critically ill ICU patients, we found that 
the CCI combined with other readily available administra-
tive data performed as well as physiology-based scoring 
systems in predicting in-hospital, 30-day, and 1-year 
mortality.
Our findings for in-hospital mortality extend data from 
four previous studies that examined the performance of 
comorbidity scores in predicting in-hospital mortality among 
ICU patients.11,16–18 In a US study including more than 17,000 
ICU patients from Veterans Affairs Medical Centers, 
Johnston et al found that the 30 comorbidity variables 
included in the Elixhauser index generated from administra-
tive databases discriminated better between in-hospital 
survivors and nonsurvivors (c-statistic = 0.700), compared 
with the chronic health evaluation component of the 
APACHE score (c-statistic = 0.568).11 The Elixhauser index 
uses 30 comorbidity variables separately and allows each 
variable to influence the outcome independently. When 
combined with other clinical data (laboratory, principal 
diagnosis, age, and admission source) the discrimination of 
the Elixhauser index was excellent (c-statistic = 0.874); 
however, some of the data used are not readily available in 
other settings – particularly laboratory, which accounted for 
67.7% of the model’s unique attributable chi square. Model 
calibration was not reported. In a 1996 US study of 201 gen-
eral ICU patients, the CCI showed less than optimal discrimi-
nating ability for in-hospital mortality (c-statistic = 0.67).18 
Data on comorbidity were collected by chart review, and the 
CCI was not combined with other administrative data. Ho 
et al found that the CCI had poor predictive performance for 
short-term mortality among 24,303 ICU patients in Western 
Australia (c-statistic # 0.610).16 This study also did not 
combine the CCI with other administrative data. A 2006 
Canadian study among 1603 ICU patients found that 
APACHE II predicted in-hospital survival better than the 
CCI (c-statistics = 0.77 versus 0.69).17
Very limited data exist on how well comorbidity scores 
and physiology-based scores predict long-term mortality of 
ICU patients. Recently, an Australian study including more 
than 11,000 ICU patients found that in a prediction model 
(PREDICT) of 1-, 5-, and 15-year mortality, age, and 
comorbidity, as measured by the CCI, were the most 
important determinants of prognosis.12 The c-index of the 
full PREDICT model was 0.757 (95% CI 0.745–0.769); 
however, no data on the performance of the CCI without 
APACHE II score in the model was presented. In the SUP-
PORT prognostic model study, Knaus et al developed a 
prediction model of 180-day mortality for ICU patients 
(c-statistics = 0.79) primarily based on diagnosis and physi-
ological variables; however, they did not include a comorbid-
ity score in their model.24
In our study, the physiology-based scoring systems per-
formed less well in predicting in-hospital mortality than 
previously reported.25 In an assessment of the performance 
of APACHE, SAPS, and MPM in 22 general ICUs in 
Scotland, Livingstone et al found good to excellent discrimi-
nation for all three scoring systems, with c-statistics ranging 
between 0.785 and 0.854.26 We obtained data on physiological 
variables from computerized databases containing 
prospectively collected data, which reduced the risk of infor-
mation bias. However, some clinical variables, in particular 
the GCS score, were missing in a number of medical records. 
and by assuming that patients with missing values had normal 
GCS scores we may have underestimated the SAPS and 
APACHE scores.22 The majority of patients in our study were 
admitted from emergency departments or following surgery 
and, therefore, were stabilized before arrival at the ICU. By 
underestimating the physiological derangement we may, thus, 
have slightly underestimated the SAPS and APACHE scores. 
We did not include patients admitted for planned postopera-
tive observation for less than 24 hours but may still have 
included some cardiac patients who, by definition, were not 
included in the original physiology-based scores. This may 
have led to an underestimation of the predictive performance 
of the physiology-based scores. The SAPS II and APACHE 
II were developed more than 20 years ago and improvements 
in treatment strategies, such as implementation of continuous 
renal replacement therapy, may explain at least a part of the 
poorer performance of the physiology-based scores. However, 
we found virtually similar predictive performances among 
SAPS II and APACHE II scores compared with the newer 
SAPS III score, suggesting that this had only minor influence 
on our results.
Based on our results, the CCI, combined with other rou-
tinely collected data from administrative medical databases, 
seem to perform at least as well as physiology-based scores 
in predicting mortality in intensive care patients. Our data 
suggest that the combination of ten separate comorbidity 
groups with other routinely collected data may perform Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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slightly better than combining the CCI with other routinely 
collected data. However, the performance of administrative 
data largely depends on the completeness and validity of 
the data. Our access to high-quality population-based medical 
databases, linked using a unique personal identifier, may 
explain the good overall performance of the administrative 
data in our study. Of note, restricting comorbidity informa-
tion to 5 years prior to ICU admission had virtually no impact 
on the performance of the CCI model. The current study was 
based on data from a general ICU. Still, since Skejby Hospital 
is the largest center for treatment of cardiovascular diseases 
in western Denmark, including heart transplant and extra-
corporeal membrane oxygenation treatment, the majority of 
patients were admitted with cardiovascular diseases as the 
primary diagnosis. APACHE II has previously been reported 
to perform less well in patients with cardiovascular diseases 
compared with general ICU patients. Thus, whether the CCI 
in combination with administrative data perform as well as 
physiology-based scores in predicting mortality in other 
settings remains to be clarified.
In conclusion, our study demonstrates that the CCI 
combined with other readily available administrative data 
performed as well as physiology-based scoring systems in 
predicting in-hospital, 30-day, and 1-year mortality.
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Table A Charlson comorbidity index and comorbidity groups
Charlson  
comorbidity  
category
Number of 
patients (%)
30-day 
mortality
ICD-8 ICD-10 Charlson 
comorbidity  
index score
Comorbidity  
groups
Myocardial  
infarction
111 (23.7%) 22.2% 410 i21; i22; i23 1 Myocardial  
infarction
Congestive  
heart failure
86 (18.3%) 20.5% 427.09; 427.10;  
427.11; 427.19;  
428.99; 782.49
i50; i11.0; i13.0;  
i13.2
1 Congestive  
heart failure
Peripheral vascular  
disease
92 (19.6%) 17.1% 440; 441; 442;  
443; 444; 445
i70; i71; i72; i73;  
i74; i77
1 Peripheral  
vascular disease
Cerebrovascular  
disease
70 (14.9%) 14.5% 430–438 i60–i69;  
g45; g46
1 Cerebrovascular   
disease
Dementia 5 (1.1%) 2.6% 290.09–290.19;  
293.09
F00–F03; F05.1;  
g30
1 -
Chronic pulmonary  
disease
94 (20.0%) 23.1% 490–493;  
515–518
J40–J47; J60–J67;  
J68.4; J70.1;  
J70.3; J84.1; J92.0;  
J96.1; J98.2; J98.3
1 Chronic 
pulmonary  
disease
Connective tissue  
disease
27 (5.8%) 5.1% 712; 716; 734;  
446; 135.99
M05; M06; M08;  
M09; M30; M31;  
M32; M33; M34;  
M35; M36; D86
1 -
Ulcer disease 48 (10.2%) 10.6% 530.91; 530.98;  
531–534
K22.1;  
K25–K28
1 Peptic ulcer  
disease
Mild liver  
disease
15 (3.2%) 3.4% 571; 573.01;  
573.04
B18;  
K70.0–K70.3;  
K70.9; K71;  
K73; K74; K76.0
1 Liver disease
Diabetes type 1 52 (11.1%) 7.7% 249.00; 249.06;  
249.07; 249.09
E10.0, E10.1;  
E10.9
1 Diabetes
Diabetes type 2 250.00; 250.06;  
250.07; 250.09
E11.0; E11.1;  
E11.9
hemiplegia 1 (0.2%) - 344 g81; g82 2 –
Moderate to severe  
renal disease
60 (12.8%) 11.1% 403; 404;  
580–583; 584;  
590.09; 593.19;  
753.10–753.19;  
792
i12; i13;  
n00–n05;  
n07; n11; n14;  
n17–n19; Q61
2 renal disease
Diabetes with end  
organ damage type 1
38 (8.1%) 6.8% 249.01–249.05;  
249.08
E10.2–E10.8 2 Diabetes
type 2 250.01–250.05;  
250.08
E11.2–E11.8
Any tumor 74 (15.8%) 17.1% 140–194 C00–C75 2 Cancer
Leukemia 3 (0.6%) 1.7% 204–207 C91–C95 2 Cancer
Lymphoma 5 (1.1%) 0.8% 200–203;  
275.59
C81–C85; C88;  
C90; C96
2 Cancer
Moderate to severe  
liver disease
5 (1.1%) 0.9% 070.00; 070.02;  
070.04; 070.06;  
070.08; 573.00;  
456.00–456.09
B15.0; B16.0;  
B16.2; B19.0;  
K70.4; K72;  
K76.6; i85
3 Liver disease
Metastatic solid tumor 2 (0.4%) 1.7% 195–198; 199 C76–C80 6 Cancer
AiDs 1 (0.2%) - 079.83 B21–B24 6 -
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Prediction of mortality following intensive care
Table C Overview of variables included in APAChE ii, sAPs ii, 
and sAPs iii
Variables APACHE II SAPS II SAPS III
Temperature x x x
Mean arterial pressure x
heart rate x x x
respiratory rate x
Oxygenation x x x
Arterial ph x x
serum sodium x x
serum potassium x x
serum creatinine/urea x x x
hematocrit x
White blood count x x x
glasgow coma scale x x x
Type of admission x
Chronic diseases x x x
Age x x x
systolic blood pressure x x
Urine output x
Bilirubin x x
hCO3 x
Length of stay before iCU  
admission
x
intra-hospital location  
before iCU admission
x
reason for iCU admission x
surgical status x
Acute infection at iCU  
admission
x
Platelets x
Abbreviations:  AIDS,  acquired  immunodeficiency  syndrome;  APACHE,  acute 
physiology  and  chronic  health  evaluations;  ICD-8,  International  Classification  of 
Diseases (Revision 8); ICD-10, International Classification of Diseases (Revision 10); 
ICU, intensive care unit; SAPS, simplified acute physiology score.
Table B Diagnostic categories
Infectious diseases (ICD-10: A00–B99)
Endocrinology including diabetes (ICD-10: E00–E90)
Cardiovascular diseases (ICD-10: I00–I99)
Respiratory diseases (ICD-10: J00–J99)
Gastrointestinal and liver disease (ICD-10: K00–K99)
Cancer (ICD-10: C00–D89)
Trauma and poisoning (ICD-10: S00–T98)
And others (ICD-10: all codes not included in other categories)